Sarah Svege
Stilling
Ph.d.-kandidat, Lege
罢颈濒丑酶谤颈驳丑别迟
Arbeid
Malaria chemoprevention in children with sickle cell disease in Malawi and Uganda
Treatment preferences, healthcare-seeking behaviour, and illness perceptions in the context of sickle cell disease
Publikasjoner
Svege, S., Rujumba, J., Robberstad, B., Lange, S.
Social Science and Medicine (2025)
Svege, S., Lange, S., Robberstad, B., Rujumba, J.
PLOS Global Public Health (2025)
Svege, S., Rujumba, J., Robberstad, B., Lange, S.
Social Science and Medicine (2024)
Lange S., Nkosi-Gondwe, T., Svege, S.
World Health Organisation (2023): WHO Guidelines for malaria,
Svege, S., Nkosi-Gondwe, T., Lange, S.
PLOS ONE (2021)
Svege, S., Lange, S., Robberstad, B.
Best Practice Nordic (2019)
Svege, S., Kaunda, B., Robberstad, B., Nkosi-Gondwe, T., Phiri, K.S, Lange, S.
BMC Health Services Research (2018)
Prosjekter
THE CHEMCHA TRIAL:
Dihydroartemisinin-piperaquine of malaria in children with sickle cell anaemia in eastern and southern Africa - the CHEMCHA trial
THE PMC STUDY:
Malaria Chemoprevention for the post-discharge management of severe anaemia in children in Malawi, Uganda and Kenya: Moving towards policy